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Background 
The diagnosis of ventilator-associated pneumonia (VAP) 
has proven to be a challenging task. Studies comparing 
invasive and non-invasive diagnostic approaches are 
lacking. 
Hypothesis 
The use of a blind protected brush is equivalent to 
bronchoscope-directed techniques in determining the 
microbiology of VAP, while endotracheal aspirates are 
contaminated with oropharyngeal flora and of little value. 
Methods 
Design: Single center, prospective cohort study. 
Setting: Level 1 trauma center at an academic medical 
center. 
Subjects: Ninety trauma patients who were mechanically 
ventilated for at least 48 hours and deemed to have clinical 
indications suggestive of pneumonia (new infiltrate on chest 
radiograph, excessive or purulent respiratory secretions, 
suspected aspiration, fever (>38.2° C), leukocytosis 
(>12,000/mm
3), or respiratory distress of unknown cause). 
Intervention: Four samplings were performed on each 
patient in the following order: blind protected brush (BPB), 
bronchoscopic-directed protected brush (BDPB), 
bronchoalveolar lavage (BAL), and endotracheal aspirates 
(ETA). Procedures were performed from least to greatest 
degree of invasiveness to avoid contamination of lower 
airways, except for ETA. 
Measurements: With patients serving as their own controls, 
quantitative cultures were obtained using each sampling 
technique. BDPB and BAL were set as the "gold standards" 
for comparison against each other and with BPB and ETA. 
Kappa analysis was used to measure the strength of 
agreement between techniques. Results were stratified by 
type of organism. 
Results 
BPB had the highest strength of agreement with both BAL 
and BDPB (κ=0.547 and κ=0.467, respectively). The 
strength of agreement between techniques was moderate to 
good for gram-negative cocci and fair to poor for gram-
negative rods and gram-positive cocci. Comparing the 
growth of specific pathogens, Haemophilus, Klebsiella, 
Escherichia, Acinetobacter, and Streptococcus correlated 
well across the majority of techniques, while Enterobacter 
agreement was consistently poor to fair. 
Using BDPB as the gold standard, BPB was found to have 
the highest sensitivity (91.1%) and specificity (89.8%). 
Sensitivities overall were higher when using BAL as the gold 
standard across all modalities. Kappa analysis comparing 
blind samples obtained from the same vs. the opposite side 
of the radiographic infiltrate found no differences between 
sides. 
Conclusion 
A quantitative analysis of bacteriologic cultures obtained by 
four standard sampling techniques demonstrated with 
statistical significance that no difference exists between Critical Care   February 2005 Vol 9 No 2   Blisard, Milbrandt, and Tisherman 
techniques in terms of reliability or obtaining clinically 
significant pathogens. 
 
Commentary 
VAP is a common disorder, occurring in 8-28% of 
mechanically ventilated patients with an associated morality 
rate of 24-50%.
2 The diagnosis of VAP has proven to be a 
challenge. Clinical indicators are neither sensitive nor 
specific and culture data can sometimes be misleading due 
to contamination and concurrent antibiotic therapy. There 
are many publications supporting quantitative cultures for 
the diagnosis of VAP, but studies comparing multiple 
sampling techniques to determine the most sensitive and 
specific method are lacking. This study attempted to 
compare four of the most common diagnostic tests (BPB, 
BDPB, BAL, ETA) to determine which is most reliable yet 
least invasive. The authors determined that there were no 
significant differences between the bronchoscopic and 
nonbronchoscopic techniques. They were careful to note, 
however, that while positive cultures appear to be reliable, a 
negative culture does not necessarily rule out infection. 
Thus, when a negative culture is obtained, and clinical 
suspicion for VAP persists, repeat sampling may be 
warranted. 
This study has a number of strengths, including using each 
patient as his own control, using explicitly defined criteria for 
quantitative culture positivity, and stratifying results by 
organism. However, this study suffers from the same 
problem that all studies in this area do: the lack of a true 
gold standard. To be sure, the authors used what many 
believe are the most reliable bronchoscopic techniques 
(BDPB and BAL) as gold standards, but even these 
methods are not 100% sensitive or specific. It has been 
suggested that only the combined results of histological 
examination and quantitative cultures of lung tissue are 
strong enough to rule in or rule out VAP in patients who 
have been mechanically ventilated for more than 3 days.
3 
Clearly, such a highly invasive sampling approach would not 
be practical in all patients. Without an indisputable and 
easily obtainable reference, calculations of sensitivity and 
specificity will remain problematic. 
A few additional limitations of this study deserve mention. 
The sampling techniques were always performed in the 
same order, potentially biasing the results; concern is raised 
about contamination by the earlier tests causing false 
readings in the later ones. Blind non-bronchoscopic BAL 
(mini-BAL), a technique that has recently gained in 
popularity, was not included. Few details are given 
regarding the study population, limiting our ability to 
determine if these results apply to other patient populations. 
Given that a true gold standard is unlikely to emerge, 
investigations have shifted from trying to determine which 
technique can best diagnose VAP to which diagnostic 
strategy leads to improved outcomes, such as morbidity, 
antimicrobial use, and mortality. Four studies have sought to 
determine if invasive strategies improve VAP outcomes.
4-7 
Each study used a different design and had important 
methodological limitations.
8 A recent meta-analysis pooled 
the results of these trials, concluding that invasive sampling 
approaches do alter antibiotic management, but do not 
appear to alter mortality.
9 The authors were careful to note, 
however, that the combined sample size may still have been 
too small to detect important clinical outcome differences. 
Recommendation 
Until compelling data are produced showing a particular 
sampling technique is superior, we recommend a VAP 
management strategy
8,10 that includes: a) initial evaluation 
with quantitative microbiology of respiratory secretions and 
immediate initiation of antimicrobial agents, and b) 
reevaluation within 2 to 3 days with adjustment or 
discontinuation of antimicrobials based on clinical course, 
culture results, and whether any noninfectious or 
nonpulmonary etiologies have been identified. 
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